QM107, a novel CD148 (RTP Type J) activating peptide therapy for treating neovascular age‐related macular degeneration
Samantha Arokiasamy(Queen Mary University of London), Giulia De Rossi(University College London)
Cited by 1
Related Papers
Autophagy modulates endothelial junctions to restrain neutrophil diapedesis during inflammation
|Immunity|2021|102
CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2021|58